Sepsis / Bloodstream Infections Webinars

Some of the contents referenced bellow are NOT owned by bioMérieux. Please note that by clicking on a link you will be redirected outside bioMérieux's website.

3rd World Sepsis Congress

On April 21st and 22nd, the Global Sepsis Alliance will host the World Sepsis Congress 2021, titled Advancing Prevention, Survival, and Survivorship of Sepsis and COVID-19.

Over the course of two days and 15 diverse and highly relevant sessions, over 90 speakers from more than 30 countries will give trenchant talks on all aspects of sepsis, from the impact of policy, the role of artificial intelligence and big data, patient safety, and long-term sequelae through to novel trial design, the latest research, and much more. The congress will take place entirely online and participation is free of charge, so you can join from wherever you have an internet connection.

For more information on program, speakers, time zones, and to register for free, please visit

Find out more

Webinar: Is COVID-19 Sepsis?

During this webinar, Professor Mervyn Singer will address the link between COVID-19 and Sepsis, a life threatening organ dysfunction caused by dysregulated host response to infection, with a “simple” question, Is COVID-19 Sepsis?


World Sepsis Congress Spotlight: Sepsis, Pandemics, and Antimicrobial Resistance – Global Health Threats of the 21st Century

In September 2020, the WHO and the GSA hosted the World Sepsis Congress Spotlight: Sepsis, Pandemics, and Antimicrobial Resistance – Global Health Threats of the 21st Century. The WSC Spotlight is an innovative free online congress bringing together over 30 renowned experts from all around the world to talk on COVID-19, antimicrobial resistance, sepsis, and how they are all linked.

Recordings of all the Spotlight’s sessions are available on the World Sepsis Congress YouTube channel.



Empowering Antibiotic Stewardship: Understanding the Use of Procalcitonin - Sepsis Alliance

This webinar, hosted by the Sepsis Alliance in January 2020, will reinforce better antibiotic use and provide strategies to better utilize the biomarker procalcitonin.




The scientific content in the above materials has been developed independently by the speaker(s)/author(s). The views presented in these materials are the authors’ personal opinions and do not necessarily represent the viewpoint, strategy or opinions of bioMérieux.

The content on this website and associated materials do not constitute medical advice and should not be considered a substitute for the individual professional judgement of any physician or other health care practitioner regarding the appropriate course of action for a particular patient. All recommendations should be independently reviewed with appropriate medical staff in light of the needs of any particular institution and its patients. bioMérieux makes no guarantee or representation regarding the accuracy, completeness, or usefulness of this information for any particular purpose, including but not limited to any cost savings.